Chapter 1. Drug of Abuse Testing Services Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Drug Type Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Drug of Abuse Testing Services Market: Executive Summary
2.1. Market Snapshot
2.2. Drug Type Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Drug of Abuse Testing Services Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. High prevalence of substance abuse & growing demand for its treatment
3.4.2. Increase in government initiatives to monitor substance abuse
3.4.3. Stringent law mandating alcohol and drug testing
3.5. Market Restraint Analysis
3.5.1. Drug testing is considered a violation of privacy rights in some countries
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
Chapter 4. Drug of Abuse Testing Services Market: Drug Type Estimates & Trend Analysis
4.1. Drug of Abuse Testing Services Market: Drug Type Movement Analysis
4.2. Alcohol
4.2.1. Alcohol Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3. Cannabis/Marijuana
4.3.1. Cannabis/Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Cocaine
4.4.1. Cocaine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Opioids
4.5.1. Opioids Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Amphetamine & Methamphetamine
4.6.1. Amphetamine & Methamphetamine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. LSD
4.7.1. LSD Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Drug of Abuse Testing Services Market: Regional Business Analysis
5.1. Regional Market Snapshot
5.2. North America
5.2.1. North America Drug of Abuse Testing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.2.2.2. Key Country Dynamics
5.2.2.3. Regulatory Framework
5.2.2.4. Reimbursement Scenario
5.2.2.5. Competitive Scenario
5.2.3. Canada
5.2.3.1. Canada Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.2.3.2. Key Country Dynamics
5.2.3.3. Regulatory Framework
5.2.3.4. Reimbursement Scenario
5.2.3.5. Competitive Scenario
5.3. Europe
5.3.1. Europe Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.2. Germany
5.3.2.1. Germany Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.2.2. Key Country Dynamics
5.3.2.3. Regulatory Framework
5.3.2.4. Reimbursement Scenario
5.3.2.5. Competitive Scenario
5.3.3. UK
5.3.3.1. UK Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.3.2. Key Country Dynamics
5.3.3.3. Regulatory Framework
5.3.3.4. Reimbursement Scenario
5.3.3.5. Competitive Scenario
5.3.4. France
5.3.4.1. France Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.4.2. Key Country Dynamics
5.3.4.3. Regulatory Framework
5.3.4.4. Reimbursement Scenario
5.3.4.5. Competitive Scenario
5.3.5. Spain
5.3.5.1. Spain Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.5.2. Key Country Dynamics
5.3.5.3. Regulatory Framework
5.3.5.4. Reimbursement Scenario
5.3.5.5. Competitive Scenario
5.3.6. Italy
5.3.6.1. Italy Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.6.2. Key Country Dynamics
5.3.6.3. Regulatory Framework
5.3.6.4. Reimbursement Scenario
5.3.6.5. Competitive Scenario
5.3.7. Denmark
5.3.7.1. Denmark Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.7.2. Key Country Dynamics
5.3.7.3. Regulatory Framework
5.3.7.4. Reimbursement Scenario
5.3.7.5. Competitive Scenario
5.3.8. Norway
5.3.8.1. Norway Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.8.2. Key Country Dynamics
5.3.8.3. Regulatory Framework
5.3.8.4. Reimbursement Scenario
5.3.8.5. Competitive Scenario
5.3.9. Sweden
5.3.9.1. Sweden Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.3.9.2. Key Country Dynamics
5.3.9.3. Regulatory Framework
5.3.9.4. Reimbursement Scenario
5.3.9.5. Competitive Scenario
5.4. Asia Pacific
5.4.1. Asia-Pacific Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.2. Japan
5.4.2.1. Japan Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.2.2. Key Country Dynamics
5.4.2.3. Regulatory Framework
5.4.2.4. Reimbursement Scenario
5.4.2.5. Competitive Scenario
5.4.3. China
5.4.3.1. China Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.3.2. Key Country Dynamics
5.4.3.3. Regulatory Framework
5.4.3.4. Reimbursement Scenario
5.4.3.5. Competitive Scenario
5.4.4. India
5.4.4.1. India Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.4.2. Key Country Dynamics
5.4.4.3. Regulatory Framework
5.4.4.4. Reimbursement Scenario
5.4.4.5. Competitive Scenario
5.4.5. Australia
5.4.5.1. Australia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.5.2. Key Country Dynamics
5.4.5.3. Regulatory Framework
5.4.5.4. Reimbursement Scenario
5.4.5.5. Competitive Scenario
5.4.6. South Korea
5.4.6.1. South Korea Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.6.2. Key Country Dynamics
5.4.6.3. Regulatory Framework
5.4.6.4. Reimbursement Scenario
5.4.6.5. Competitive Scenario
5.4.7. Thailand
5.4.7.1. Thailand Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.4.7.2. Key Country Dynamics
5.4.7.3. Regulatory Framework
5.4.7.4. Reimbursement Scenario
5.4.7.5. Competitive Scenario
5.5. Latin America
5.5.1. Latin America Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.5.2.2. Key Country Dynamics
5.5.2.3. Regulatory Framework
5.5.2.4. Reimbursement Scenario
5.5.2.5. Competitive Scenario
5.5.3. Mexico
5.5.3.1. Mexico Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.5.3.2. Key Country Dynamics
5.5.3.3. Regulatory Framework
5.5.3.4. Reimbursement Scenario
5.5.3.5. Competitive Scenario
5.5.4. Argentina
5.5.4.1. Argentina Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.5.4.2. Key Country Dynamics
5.5.4.3. Regulatory Framework
5.5.4.4. Reimbursement Scenario
5.5.4.5. Competitive Scenario
5.6. MEA
5.6.1. MEA Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.2. South Africa
5.6.2.1. South Africa Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.2.2. Key Country Dynamics
5.6.2.3. Regulatory Framework
5.6.2.4. Reimbursement Scenario
5.6.2.5. Competitive Scenario
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.3.2. Key Country Dynamics
5.6.3.3. Regulatory Framework
5.6.3.4. Reimbursement Scenario
5.6.3.5. Competitive Scenario
5.6.4. UAE
5.6.4.1. UAE Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.4.2. Key Country Dynamics
5.6.4.3. Regulatory Framework
5.6.4.4. Reimbursement Scenario
5.6.4.5. Competitive Scenario
5.6.5. Kuwait
5.6.5.1. Kuwait Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
5.6.5.2. Key Country Dynamics
5.6.5.3. Regulatory Framework
5.6.5.4. Reimbursement Scenario
5.6.5.5. Competitive Scenario
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.2.1. New Launch
6.2.2. Partnerships
6.2.3. Acquisition
6.2.4. Collaboration
6.3. Key Company Market Share Analysis, 2022
6.4. Company Heat Map Analysis
6.5. Company Profiles
6.5.1. QUEST DIAGNOSTICS
6.5.1.1. Company Overview
6.5.1.2. Financial Performance
6.5.1.3. Product Benchmarking
6.5.1.4. Strategic Initiatives
6.5.2. ABBOTT
6.5.2.1. Company Overview
6.5.2.2. Financial Performance
6.5.2.3. Product Benchmarking
6.5.2.4. Strategic Initiatives
6.5.3. CLINICAL REFERENCE LABORATORY (CRL), INC.
6.5.3.1. Company Overview
6.5.3.2. Financial Performance
6.5.3.3. Product Benchmarking
6.5.3.4. Strategic Initiatives
6.5.4. LABORATORY CORPORATION OF AMERICA HOLDINGS
6.5.4.1. Company Overview
6.5.4.2. Financial Performance
6.5.4.3. Product Benchmarking
6.5.4.4. Strategic Initiatives
6.5.5. CORDANT HEALTH SOLUTIONS
6.5.5.1. Company Overview
6.5.5.2. Financial Performance
6.5.5.3. Product Benchmarking
6.5.5.4. Strategic Initiatives
6.5.6. LEGACY MEDICAL SERVICES
6.5.6.1. Company Overview
6.5.6.2. Financial Performance
6.5.6.3. Product Benchmarking
6.5.6.4. Strategic Initiatives
6.5.7. DRUGSCAN
6.5.7.1. Company Overview
6.5.7.2. Financial Performance
6.5.7.3. Product Benchmarking
6.5.7.4. Strategic Initiatives
6.5.8. OMEGA LABORATORIES, INC.
6.5.8.1. Company Overview
6.5.8.2. Financial Performance
6.5.8.3. Product Benchmarking
6.5.8.4. Strategic Initiatives
6.5.9. PSYCHEMEDICS CORPORATION
6.5.9.1. Company Overview
6.5.9.2. Financial Performance
6.5.9.3. Product Benchmarking
6.5.9.4. Strategic Initiatives
6.5.10. MILLENNIUM HEALTH, LLC
6.5.10.1. Company Overview
6.5.10.2. Financial Performance
6.5.10.3. Product Benchmarking
6.5.10.4. Strategic Initiatives
6.5.11. MAYO CLINIC LABORATORIES
6.5.11.1. Company Overview
6.5.11.2. Financial Performance
6.5.11.3. Product Benchmarking
6.5.11.4. Strategic Initiatives
6.5.12. PRECISION DIAGNOSTICS
6.5.12.1. Company Overview
6.5.12.2. Financial Performance
6.5.12.3. Product Benchmarking
6.5.12.4. Strategic Initiatives
6.5.13. AMERICAN SUBSTANCE ABUSE PROFESSIONALS (ASAP), INC.
6.5.13.1. Company Overview
6.5.13.2. Financial Performance
6.5.13.3. Product Benchmarking
6.5.13.4. Strategic Initiatives
6.5.14. UNITED STATES DRUG TESTING LABORATORIES (USDTL), INC.
6.5.14.1. Company Overview
6.5.14.2. Financial Performance
6.5.14.3. Product Benchmarking
6.5.14.4. Strategic Initiatives
6.5.15. LGC GROUP
6.5.15.1. Company Overview
6.5.15.2. Financial Performance
6.5.15.3. Product Benchmarking
6.5.15.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Drug of Abuse Testing Services Market, By Region, 2018 - 2030 (USD Million)
Table 4 North America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 5 North America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 6 U.S. Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 7 Canada Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 8 Europe Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 9 Europe Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 10 Germany Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 11 UK Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 12 France Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 13 Spain Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 14 Italy Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 15 Denmark Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 16 Norway Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 17 Sweden Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 18 Asia Pacific Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 19 Asia Pacific Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 20 Japan Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 21 China Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 22 India Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 23 Australia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 24 South Korea Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 25 Thailand Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 26 Latin America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 27 Latin America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 28 Brazil Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 29 Mexico Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 30 Argentina Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 31 Middle East & Africa Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
Table 32 Middle East & Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 33 Saudi Arabia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 34 South Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 35 UAE Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
Table 36 Kuwait Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global drug of abuse testing services market - Key market driver analysis
Fig. 7 Global drug of abuse testing services market - Key market restraint analysis
Fig. 8 Penetration & growth prospect mapping
Fig. 9 Global drug of abuse testing services market - Porter’s analysis
Fig. 10 Global drug of abuse testing services market - PESTEL analysis
Fig. 11 Global drug of abuse testing services market drug type outlook key takeaways
Fig. 12 Global drug of abuse testing services market: Drug type movement analysis
Fig. 13 Alcohol market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Cannabis/Marijuana market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Cocaine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Opioids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Amphetamine & Methamphetamine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 LSD market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Regional marketplace: Key takeaways
Fig. 21 Global drug of abuse testing services market: Regional movement analysis
Fig. 22 North America drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 23 U.S. drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 24 Canada drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 25 Europe drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 26 Germany drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 27 UK drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 28 France drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 29 Spain drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 30 Italy drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 31 Denmark drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 32 Norway drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 33 Sweden drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 34 Asia Pacific drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 35 Japan drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 36 China drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 37 India drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 38 Australia drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 39 South Korea drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 40 Thailand drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 41 Latin America drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 42 Brazil drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 43 Mexico drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 44 Argentina drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 45 MEA drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 46 South Africa drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 47 Saudi Arabia drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 48 UAE drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 49 Kuwait drug of abuse testing services market, 2018 - 2030 (USD Million)
Fig. 50 Strategy framework